QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Prostate cancer (CaP) is a complex disease involving multiple steps and pathways to the development of cancer. Each step involves one or more genetic changes. Family studies have found varying degrees of clustering of prostate cancer in certain families, suggesting…
(Is 98% rate of non-recurrence a realistic goal?) Why a patient’s column? This is not a doctors column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patients perspective…
Each year, Dr. Catalona and his research collaborators deliver their research findings at the American Urological Association (AUA) annual meeting. In the last issue of QUEST, we summarized findings from recent research projects of Dr. Catalona and his collaborators. The…
John Clark is an athlete a middle-aged athlete who was treated for prostate cancer last year. His career, until he retired at 54, was athletic director for St. Lawrence University. His children, seven of them, are athletes too. Naturally…
Misop Han, M.D.; Peter H. Gann, M.D., Sc.D.; William J. Catalona, M.D. prepared a paper on PSA and Screening for Prostate Cancer for the journal Medical Clinics of North America. This article is a portion of that paper revised by…
"*" indicates required fields
